These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 23429812)

  • 1. Psychosocial and clinical predictors of retention in outpatient alcoholism treatment.
    Corrêa Filho JM; Baltieri DA
    Braz J Psychiatry; 2012 Dec; 34(4):413-21. PubMed ID: 23429812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of two clusters of male alcoholics in treatment retention.
    Baltieri DA; Corrêa Filho JM
    Eur Addict Res; 2012; 18(4):201-11. PubMed ID: 22507891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of dropout in an outpatient treatment for problem drinkers including cognitive-behavioral therapy and the opioid antagonist naltrexone.
    Vuoristo-Myllys S; Lahti J; Alho H; Julkunen J
    J Stud Alcohol Drugs; 2013 Nov; 74(6):894-901. PubMed ID: 24172116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attrition from conjoint alcoholism treatment: do dropouts differ from completers?
    Epstein EE; McCrady BS; Miller KJ; Steinberg M
    J Subst Abuse; 1994; 6(3):249-65. PubMed ID: 7703703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in depression mediate the effects of AA attendance on alcohol use outcomes.
    Wilcox CE; Tonigan JS
    Am J Drug Alcohol Abuse; 2018; 44(1):103-112. PubMed ID: 27892692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Issues in the implementation of a randomized clinical trial that includes Alcoholics Anonymous: studying AA-related behaviors during treatment.
    McCrady BS; Epstein EE; Hirsch LS
    J Stud Alcohol; 1996 Nov; 57(6):604-12. PubMed ID: 8913991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AA utilization after introduction in outpatient treatment.
    Thomassen L
    Subst Use Misuse; 2002 Jan; 37(2):239-53. PubMed ID: 11863278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of long-term AA attendance and spirituality on the course of depressive symptoms in individuals with alcohol use disorder.
    Wilcox CE; Pearson MR; Tonigan JS
    Psychol Addict Behav; 2015 Jun; 29(2):382-91. PubMed ID: 26076099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence with naltrexone prescription advice in hospital outpatient alcohol rehabilitation programme.
    Feeney GF; Connor JP; Young RM; Tucker J; Czajkowski F
    J Clin Pharm Ther; 2001 Feb; 26(1):73-9. PubMed ID: 11286610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism.
    Kampman KM; Pettinati HM; Lynch KG; Whittingham T; Macfadden W; Dackis C; Tirado C; Oslin DW; Sparkman T; O'Brien CP
    J Clin Psychopharmacol; 2007 Aug; 27(4):344-51. PubMed ID: 17632217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of alcoholic beverage preference in the severity of alcohol dependence and adherence to the treatment.
    Baltieri DA; Daró FR; Ribeiro PL; De Andrade AG
    Alcohol; 2009 May; 43(3):185-95. PubMed ID: 19269773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of dropout in concurrent treatment of posttraumatic stress disorder and alcohol dependence: Rate of improvement matters.
    Zandberg LJ; Rosenfield D; Alpert E; McLean CP; Foa EB
    Behav Res Ther; 2016 May; 80():1-9. PubMed ID: 26972745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with patient dropout from an outpatient alcoholism treatment service.
    Leigh G; Ogborne AC; Cleland P
    J Stud Alcohol; 1984 Jul; 45(4):359-62. PubMed ID: 6482440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of patient characteristics to program attendance by women alcoholics.
    Bander KW; Stilwell NA; Fein E; Bishop G
    J Stud Alcohol; 1983 Mar; 44(2):318-27. PubMed ID: 6645516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the onset of compulsive drinking in alcoholics: a biopsychosocial model.
    Wallace J
    Alcohol; 1985; 2(4):589-95. PubMed ID: 4026983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study of full-dose ondansetron to treat heavy-drinking men withdrawing from alcohol in Brazil.
    Corrêa Filho JM; Baltieri DA
    Addict Behav; 2013 Apr; 38(4):2044-51. PubMed ID: 23396176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Help-seeking for alcohol-related problems: social contexts surrounding entry into alcoholism treatment or Alcoholics Anonymous.
    George AA; Tucker JA
    J Stud Alcohol; 1996 Jul; 57(4):449-57. PubMed ID: 8776687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Craving Mediates Stress in Predicting Lapse During Alcohol Dependence Treatment.
    Law B; Gullo MJ; Daglish M; Kavanagh DJ; Feeney GF; Young RM; Connor JP
    Alcohol Clin Exp Res; 2016 May; 40(5):1058-64. PubMed ID: 27012658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of first-time alcohol treatment seekers: the COMBINE Study.
    Locastro JS; Potter JS; Donovan DM; Couper D; Pope KW
    J Stud Alcohol Drugs; 2008 Nov; 69(6):885-95. PubMed ID: 18925347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study.
    Addolorato G; Caputo F; Capristo E; Domenicali M; Bernardi M; Janiri L; Agabio R; Colombo G; Gessa GL; Gasbarrini G
    Alcohol Alcohol; 2002; 37(5):504-8. PubMed ID: 12217947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.